Summary
In the last few years complete or partial regression of prolactinomas has been demonstrated in nonpregnant women treated by bromocriptine. Thus bromocriptine therapy appears as an attractive alternative to surgery for management of infertility related to hyperprolactinemia. However, numerous reports emphasized the possibility of an excessive growth of the pituitary adenoma with visual field defects during the last 3 months of pregnancy. To avoid these complications, the authors followed with serial CT scans the growth of microprolactinoma at the 5th or 6th month of pregnancy. Among six pregnant women, one patient presented a marked upward extension of the adenoma. Bromocriptine was then reintroduced and the effectiveness in reducing tumor growth was proved by CT scan at the 7th month. Regarding low risk of using intravenous iodinated contrast medium in pregnant women and of fetal radiation damage, the authors emphasize the value of CT in the follow-up of bromocriptine-induced pregnancies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Corenblum B, Webster BR, Mortimer CB, Ezrin C (1978) Bromocriptine in pituitary tumours. Lancet II: 786
Nillius SJ, Bergh T, Lundberg PO, Stahle J, Wide L (1978) Regression of a prolactin-secreting pituitary tumor during longterm treatment with bromocriptine. Fertil Steril 30: 710–712
Hancock KW, Scott JS, Lamb JT, Gibson RM, Chapman C (1980) Conservative management of pituitary prolactinomas; evidence for bromocriptine-induced regression. Br J Obstet Gynaecol 87: 523–529
Wollesen F, Andersen T, Karle A (1982) Size reduction of extrasellar pituitary tumors during bromocriptine treatment. Ann Intern Med 96: 281–286
McGregor AM, Scanlon MF, Hall R, Hall K (1979) Effects of bromocriptine on pituitary tumour size. Br Med J 2: 700–703
Sobrinho LG, Nunes MC, Calhaz-Jorge C, Mauricio JC, Santos MA (1981) Effect of treatment with bromocriptine on the size and activity of prolactin producing pituitary tumours. Acta Endocrinol 96: 24–29
Landolt AM, Wüthrich R, Fellmann H (1979) Regression of pituitary prolactinoma after treatment with bromocriptine. Lancet I: 1082–1083
Metzger J, Gardeur D, Pehuet M, Houlbert D (1982) Contrôle radiologique des adénomes à prolactine traités par la bromocriptine. Ann Med Interne (Paris) 133: 59–60
Velentzas C, Carras D, Vassilouthis J (1981) Regression of pituitary prolactinoma with bromocriptine administration. JAMA 245: 1149–1150
Bonneville JF, Poulignot D, Cattin F, Couturier M, Mollet E, Dietemann JL (1982) Computed tomographic demonstration of the effects of bromocriptine on pituitary microadenoma size. Radiology 143: 451–455
Hardy J, Mohr G (1981) Prolactinoma: surgical aspects. In: Hardy J (ed) Prolactinoma. Masson, Paris New York
van Dalen JTW, Greve EL (1977) Rapid deterioration of visual fields during bromocriptine-induced pregnancy in a patient with a pituitary adenoma. Br J Ophthalmol 61: 729–733
Nelson PB, Robinson AG, Archer DF, Maroon JC (1978) Symptomatic pituitary tumor enlargement after induced pregnancy. J Neurosurg 49: 283–287
Syvertsen A, Haughton VM, Williams AL, Cusick JF (1979) The computed tomographic appearance of the normal pituitary gland and pituitary microadenomas. Radiology 133: 385–391
Chambers EF, Turski PA, La Masters D, Newton TH (1982) Regions of low density in the contrast-enhanced pituitary gland: normal and pathologic processes. Radiology 144: 109–113
Bonneville JF, Dietemann JL (1981) Radiology of the sella turcica. Springer, Berlin Heidelberg New York, pp 219–226
Etling N, Gehin-Fouque F, Vielh JP, Gautray JP (1979) The iodine content of amniotic fluid and placental transfer of iodinated drugs. Obstet Gynecol 53: 376–380
Denavit MF, Lecointre C, Mallet E, Menibus de C, Rosier A (1977) Un accident de l'amniofoetographie: l'hypothyroidie. Arch Fr Pediatr 34: 543–551
Federle MP, Cohen HA, Rosenwein MF, Brant-Zawadzki MN, Cann CE (1982) Pelvimetry by digital radiography: a low-dose examination. Radiology 143: 733–735
McCullough EC, Payne JT (1978) Patient dosage in computed tomography. Radiology 129: 457–463
Shanklin WM (1949) On the presence of cysts in the human pituitary. Anat Rec 104: 379–407
Dietemann JL, Bonneville JF, Buchheit F, Cattin F, Heldt N, Wackenheim A (1983) CT finding in symptomatic Rathke's cleft cysts of the pituitary gland. Report of three cases. Neuroradiology 24: 263–267
Rasmussen AT (1924) Quantitative study of human hypophysis cerebri or pituitary body. Endocrinology 8: 509–524
Mornex R, Orgiazzi J, Hugues B, Gagnaire JC, Claustrat B (1978) Normal pregnancies after treatment of hyperprolactinemia with bromoergocryptine, despite suspected tumors. J Clin Endocrinol Metab 47: 290–295
Bergh T, Nillius SJ, Wide L (1978) Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinemia and pituitary tumours. Br Med J 1: 875–880
Gemzell C, Wang CF (1979) Outcome of pregnancy in women with pituitary adenoma. Fertil Steril 31: 363–372
Thorner MO, Edwards CRW, Charlesworth M, Dacie JE, Moult RJA, Rees LH, Jones AE, Besser GM (1979) Pregnancy in patients presenting with hyperprolactinemia. Br Med J 2: 771–774
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dietemann, J.L., Portha, C., Cattin, F. et al. CT follow-up of microprolactinomas during bromocriptine-induced pregnancy. Neuroradiology 25, 133–138 (1983). https://doi.org/10.1007/BF00455732
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00455732